DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 074530
The generic ingredient in TERAZOSIN HYDROCHLORIDE is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.
Summary for 074530
Tradename: | TERAZOSIN HYDROCHLORIDE |
Applicant: | Ivax Sub Teva Pharms |
Ingredient: | terazosin hydrochloride |
Patents: | 0 |
Therapeutic Class: | Cardiovascular Agents Genitourinary Agents |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Apr 21, 2000 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Apr 21, 2000 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Apr 21, 2000 | TE: | RLD: | No |
Complete Access Available with Subscription